Diffusion Kurtosis imaging: a possible MRI biomarker for Alzheimer's disease diagnosis?

Manuscript Number: 

15-0253R2

Author(s): 
Frank De Belder, Maya De Belder, Sebastiaan Engelborghs, Paul M. Parizel, Benjamin Peters, Caroline Robberecht, Jan Sijbers, Sylvie Slaets, Kristel Sleegers, Hanne Struyfs, Christine Van Broeckhoven, Wim Van Hecke, Jelle Veraart, Laura Wuyts

Disclosures

Maya De Belder

  • Nothing to Disclose

Frank De Belder

  • Nothing to Disclose

Sebastiaan Engelborghs

  • Consulting Fees:
    consulting fees from Janssen, Innogenetics / Fujirebio Europe, Pfizer, Novartis, UCB, Roche diagnostics, Nutricia / Danone
    Grants
    • Agency: 
      Janssen Pharmaceutica NV
      Dates: 
      1 SEP 2012

Paul M. Parizel

  • Nothing to Disclose
    Lecture Fees:
    Bracco: lecture about an MRI contrast agent Multihance General Electric: invited lecture about the impact of "big data" in radiation dose management

Benjamin Peters

  • Nothing to Disclose

Caroline Robberecht

  • Nothing to Disclose

Jan Sijbers

  • Nothing to Disclose

Sylvie Slaets

  • Nothing to Disclose

Kristel Sleegers

  • Nothing to Disclose

Hanne Struyfs

  • Nothing to Disclose

Christine Van Broeckhoven

  • Grants
    • Agency: 
      Janssen Pharmaceutica
      Dates: 
      01-01-2015 to 31-12-2016

Wim Van Hecke

  • Equity:
    I have shares of icometrix

Jelle Veraart

  • Nothing to Disclose

Laura Wuyts

  • Nothing to Disclose